Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial.
Barbara M McGowanAzadeh Houshmand-OeregaardPeter Nørkjaer LaursenNiels ZeuthenJames Baker-KnightPublished in: Obesity (Silver Spring, Md.) (2023)
, including in those with comorbidities.
Keyphrases